Concepedia

Kimberly Loo

KL

Statistics

Publications

8

Citations

2.4K

H-Index

8

Active since

2009

Affiliations

University of California, San Francisco(Current)

Angeles Clinic and Research Institute

UCSF Helen Diller Family Comprehensive Cancer Center

University of San Francisco

University Hospital of Zurich

Kimberly Loo is an author at University of California, San Francisco specializing in cancer immunotherapy, oncology, and immunotherapy.

ORCID

Publications per year

2009–2018

8

Publications

8

A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments

Kevin C. Barry, Joy Hsu, Miranda L. Broz et al. · Nature Medicine · 2018 · 1K citations

, , +10

Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC

Paul C. Tumeh, Matthew D. Hellmann, Omid Hamid et al. · Cancer Immunology Research · 2017 · 565 citations · Full text

, , +17

Tumor immune profiling predicts response to anti–PD-1 therapy in human melanoma

Adil Daud, Kimberly Loo, Mariela Pauli et al. · Journal of Clinical Investigation · 2016 · 527 citations · Full text

, , +17

Evaluation of clinicopathological factors in PD-1 response: derivation and validation of a prediction scale for response to PD-1 monotherapy

Adi Nosrati, Katy K. Tsai, Simone M. Goldinger et al. · British Journal of Cancer · 2017 · 128 citations · Full text

, , +17

Partially exhausted tumor-infiltrating lymphocytes predict response to combination immunotherapy

Kimberly Loo, Katy K. Tsai, Kelly M. Mahuron et al. · JCI Insight · 2017 · 79 citations · Full text

, , +17

1–5 of 8